|
Press Releases
16 FEB, 2004
Alteris licenses rights from Duke and Johns Hopkins to cancer vaccine
targeting variant EGF receptor
Read More......
19 NOV, 2004
ANTI-CANCER VACCINE DOUBLES TIME-TO-DISEASE PROGRESSION AND INCREASES
SURVIVAL IN PHASE I BRAIN CANCER TRIAL
Read More......
|
